XML 62 R43.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Option Pricing Assumptions and Estimated Fair Value
The following table presents the option pricing assumptions and the estimated fair value of the options using these assumptions for grants made for the year ended:
 
December 31,
 
2018
 
2017
 
2016
Weighted-average dividend yield
2.36
%
 
N/A
 
3.12
%
Weighted-average risk-free interest rate
2.38
%
 
N/A
 
1.52
%
Weighted-average expected volatility
22.80
%
 
N/A
 
29.64
%
Weighted-average expected life (in years)
5.3

 
N/A
 
5.3

Weighted-average fair value of options granted
$
7.78

 
N/A
 
$
5.17

Schedule of Stock Option Activity
Stock option activity for the year ended December 31, 2018 was as follows:
 
 
Number of Options
 
Weighted-Average
Exercise Price per Option
 
Weighted-Average
Remaining
Contractual Term
(Years)
 
Aggregate Intrinsic Value
Options outstanding at January 1, 2018
 
43,077

 
$
21.00

 
  
 
 
Granted
 
1,000

 
42.44

 
  
 
  

Exercised
 
(15,975
)
 
19.64

 
  
 
  

Forfeited
 
(750
)
 
22.40

 
 
 
 
Expired
 

 

 
 
 
 
Options outstanding at December 31, 2018
 
27,352

 
$
22.53

 
3.4
 
$
374

Options exercisable at December 31, 2018
 
24,252

 
$
21.44

 
2.9
 
$
352



A summary of the status of the Company’s nonvested stock options as of December 31, 2018 and changes during the year then ended was as follows:
 
Options
 
Weighted-Average
Grant Date
Fair Value per Option
Nonvested at January 1, 2018
3,450

 
$
6.11

Granted
1,000

 
7.78

Vested
(1,350
)
 
6.85

Forfeited

 

Nonvested at December 31, 2018
3,100

 
$
6.32

Schedule of Compensation Expense
Compensation expense and the related tax benefit recognized in connection with the DCRP was as follows for the periods presented:
 
For The Year Ended
December 31,
  
2018
 
2017
 
2016
Compensation expense
$
106

 
$
97

 
$
81

Related income tax benefit
23

 
21

 
28

Fair value of grants vested
105

 
90

 
75

Compensation expense and the related tax benefit for the LTIP's performance-based awards was as follows for the periods indicated:
 
For The Year Ended
December 31,
  
2018
 
2017
 
2016
Compensation expense
$
291

 
$
370

 
$
1,080

Related income tax benefit
63

 
80

 
378

Fair value of grants vested
284

 
843

 
725

Compensation expense and the related income tax benefit recognized in connection with the restricted stock units was as follows for the periods indicated:
 
For The Year Ended
December 31,
  
2018
 
2017
 
2016
Compensation expense
$
263

 
$
124

 
$

Income tax benefit
57

 
27

 

Fair value of grants vested
149

 

 

Compensation expense and the related income tax benefit recognized in connection with the MSPP awards was as follows for the periods indicated:
 
For The Year Ended
December 31,
  
2018
 
2017
 
2016
Compensation expense
$
104

 
$
97

 
$
102

Income tax benefit
22

 
21

 
36

Fair value of grants vested
130

 
91

 
57

Compensation expense and the related income tax benefit recognized in connection with the restricted stock awards was as follows for the periods indicated:
 
For The Year Ended
December 31,
  
2018
 
2017
 
2016
Compensation expense
$
916

 
$
762

 
$
703

Income tax benefit
197

 
164

 
246

Fair value of grants vested
931

 
702

 
603

Summary of Nonvested Share Awards Activity
LTIP performance-based award activity for the year ended December 31, 2018 was as follows:
  
 
Number of Shares
 
Weighted-Average
Grant Date
Fair Value per Share
 
Weighted-Average
Remaining
Contractual Term
(Years)
 
Aggregate Intrinsic Value
 
Unrecognized
Compensation
Nonvested at January 1, 2018
 
31,623

 
$
35.60

 
  
 
  

 
 
Granted
 
14,886

 
44.56

 
  
 
  

 
 
Vested
 
(9,844
)
 
28.87

 
 
 
 
 
 
Forfeited
 
(10,288
)
 
32.75

 
 
 
 
 
 
Nonvested at December 31, 2018
 
26,377

 
$
44.28

 
1.7
 
$
949

 
$
314

MSPP award activity for the year ended December 31, 2018 was as follows:
  
 
Number of Shares
 
Weighted-Average
Grant Date
Fair Value per Share
 
Weighted-Average
Remaining
Contractual Term
(Years)
 
Aggregate Intrinsic Value
 
Unrecognized
Compensation
Nonvested at January 1, 2018
 
20,219

 
$
9.77

 
  
 
  

 
 
Granted
 
9,372

 
14.85

 
  
 
  

 
 
Vested
 
(15,207
)
 
8.56

 
 
 
 
 
 
Forfeited
 
(1,371
)
 
14.34

 
 
 
 
 
 
Nonvested at December 31, 2018
 
13,013

 
$
14.35

 
0.8
 
$
84

 
$
71

DCRP award activity for the year ended December 31, 2018 was as follows:
  
 
Number of Deferred Stock Awards
 
Weighted-Average
Grant Date
Fair Value per Award
 
Weighted-Average
Remaining
Contractual Term
(Years)
 
Aggregate Intrinsic Value
 
Unrecognized
Compensation
Nonvested at January 1, 2018
 
10,048

 
$
25.52

 
  
 
  

 
 
Granted
 
3,434

 
45.23

 
  
 
  

 
 
Vested
 
(2,899
)
 
36.46

 
 
 
 
 
 
Forfeited
 
(613
)
 
41.56

 
 
 
 
 
 
Nonvested at December 31, 2018
 
9,970

 
$
28.16

 
10.9
 
$
359

 
$
251

Restricted stock award activity for the year ended December 31, 2018 is as follows:
  
 
Number of Shares
 
Weighted-Average
Grant Date
Fair Value per Share
 
Weighted-Average
Remaining
Contractual Term
(Years)
 
Aggregate Intrinsic Value
 
Unrecognized
Compensation
Nonvested at January 1, 2018
 
36,325

 
$
32.56

 
  
 
  

 
 
Granted
 
17,033

 
44.19

 
 
 
  

 
 
Vested
 
(26,527
)
 
35.11

 
 
 
 
 
 
Forfeited
 
(4,050
)
 
32.96

 
 
 
 
 
 
Nonvested at December 31, 2018
 
22,781

 
$
38.21

 
1.8
 
$
819

 
$
531

Restricted stock unit activity for the year ended December 31, 2018 was as follows:
  
 
Number of Units
 
Weighted-Average
Grant Date
Fair Value per Unit
 
Weighted-Average
Remaining
Contractual Term
(Years)
 
Aggregate Intrinsic Value
 
Unrecognized
Compensation
Nonvested at January 1, 2018
 
17,477

 
$
43.04

 
  
 
  

 
 
Granted
 
19,695

 
45.06

 
  
 
  

 
 
Vested
 
(3,455
)
 
43.04

 
 
 
 
 
 
Forfeited
 
(3,492
)
 
44.13

 
 
 
 
 
 
Nonvested at December 31, 2018
 
30,225

 
$
44.23

 
3.7
 
$
1,087

 
$
1,090